klebsiella pneumoniae vaccine

This Klebsiella pneumoniae vaccine is a prophylactic candidate under development by Shenzhen Kangtai Biological Products (BioKangtai). It is designed to prevent infections caused by the Gram-negative bacterium *Klebsiella pneumoniae*, a major cause of hospital-acquired pneumonia and other serious infections, particularly those involving multi-drug resistant strains. The vaccine aims to induce active immunity, likely targeting surface antigens of the bacteria to facilitate pathogen recognition and clearance by the host immune system. As of the current reporting, the project is in the preclinical stage, and specific details regarding the vaccine platform (e.g., conjugate, subunit, or inactivated) and the specific serotypes covered have not been disclosed.

Other names

肺炎克雷伯菌疫苗